Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TARLATAMAB-DLLE vs TASIGNA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TARLATAMAB-DLLE vs TASIGNA: Safety Overview

Metric TARLATAMAB-DLLE TASIGNA
Total FAERS Reports 804 772
Deaths Reported 103 139
Death Rate 12.8% 18.0%
Hospitalizations 206 180
Average Patient Age 69.8 yrs 60.5 yrs
% Female Patients 43.6% N/A
Manufacturer Amgen, Inc N/A
Marketing Status Prescription N/A